Skip to main content
. 2016 Mar 7;5(2):155–168. doi: 10.2217/cer.15.60

Table 1. . Key sociodemographic and health characteristics of study patients, overall and by randomization status.

Key characteristics Enrolled (n = 845) Included in 12-month analysis (n = 581) Usual home care (n = 206) Basic intervention (n = 189) Augmented intervention (n = 186)
Socio-demographic characteristics
Age:          
– Mean age in years (SD) 64.3 (10.9) 64.2 (10.8) 63.3 (10.5) 65.1(10.4) 64.4 (11.1)
– 65+
0.53
0.51
0.46
0.58
0.49
Gender: female
0.66
0.67
0.66
0.65
0.70
Education:          
– Less than high school 0.40 0.40 0.43 0.42 0.35†,‡
– High school or more
0.60
0.60
0.57
0.58
0.65
Medicaid enrollee
0.44
0.45
0.48
0.47
0.41
Baseline health status
Comorbidity score, mean (SD)
3.8 (2.8)
3.7 (2.8)
3.8 (3.0)
3.6 (2.6)
3.8 (2.6)
Overweight§
0.26
0.27
0.26
0.31
0.24
Obese§
0.44
0.45
0.45
0.40
0.50
Diabetes
0.59
0.61
0.55
0.66
0.62
Years with HTN dx, mean (SD)
13.6 (12.2)
13.6 (12.1)
13.1 (12.0)
14.0 (12.0)
13.7 (12.6)
Blood pressure status at baseline
SBP, mmHg (SD)
155.5 (20.4)
154.8 (20.1)
154.5 (19.1)
155.7 (21.5)
154.1 (19.9)
DBP, mmHg (SD)
87.3 (13.0)
87.0 (13.4)
87.6 (13.3)
86.5(14.3)
87.0 (12.4)
JNC7-stage 2
0.54
0.53
0.52
0.56
0.51
SBP among stage 2 (SD)
168.4 (18.6)
167.6 (18.8)
166.6 (18.1)
168.3 (20.2)
167.9 (18.2)
DBP among stage 2 (SD)
92.5 (13.2)
93.0 (13.3)
93.0 (13.9)
93.0 (14.1)
93.1 (11.9)
Number of HTN medications, mean (SD) 2.27 (1.23) 2.25 (1.20) 2.21 (1.17) 2.27 (1.25) 2.28 (1.20)

Significantly different from usual care group at the p < 0.05 level.

Significantly different from basic intervention group at the p < 0.05 level.

§Height and weight were collected to calculate body mass index (BMI); overweight is defined as BMI between 25 and 30; obesity is defined as BMI >30.

DBP: Diastolic blood pressure; HTN: Hypertension; JNC7: Joint National Committee Report; SBP: Systolic blood pressure; SD: Standard deviation.